期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 210, 期 7, 页码 1447-1462出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20122494
关键词
-
资金
- National Institutes of Health (NIH) [P01 DK072201, R56AI091871]
- Broad Medical Research Program of The Broad Foundation
- National Natural Science Foundation of China [30972504]
- National Important Project on Scientific Research of China [2011CB933404]
- Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases
ROR gamma t is necessary for the generation of T(H)17 cells but the molecular mechanisms for the regulation of T(H)17 cells are still not fully understood. We show that activation of CD4(+) T cells results in the expression of inducible nitric oxide synthase (iNOS). iNOS-deficient mice displayed enhanced T(H)17 cell differentiation but without major effects on either T(H)1 or T(H)2 cell lineages, whereas endothelial NOS (eNOS) or neuronal NOS (nNOS) mutant mice showed comparable T(H)17 cell differentiation compared with wild-type control mice. The addition of N6-(1-iminoethyl)-L-lysine dihydrochloride (L-NIL), the iNOS inhibitor, significantly enhanced T(H)17 cell differentiation, and S-nitroso-N-acetylpenicillamine (SNAP), the NO donor, dose-dependently reduced the percentage of IL-17-producing CD4(+) T cells. NO mediates nitration of tyrosine residues in ROR gamma t, leading to the suppression of ROR gamma t-induced IL-17 promoter activation, indicating that NO regulates IL-17 expression at the transcriptional level. Finally, studies of an experimental model of colitis showed that iNOS deficiency results in more severe inflammation with an enhanced T(H)17 phenotype. These results suggest that NO derived from iNOS in activated T cells plays a negative role in the regulation of T(H)17 cell differentiation and highlight the importance of intrinsic programs for the control of T(H)17 immune responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据